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Brief Clinical Reportspulmonary atresia, (2) associated with systemic obstruc-
tion–aortic arch interruption, and (3) with unrestricted
systemic and pulmonary flows. PFAA might be asymptom-
atic when it forms a subclavian artery arising from the
ascending aorta (type A3)3 or a double-lumen (subway)
type of aortic arch in the absence of aortic interruption or
coarctation (type A1).1 No intervention is needed in such
patients. At the other end of the spectrum, it might be an
isolated anomaly connecting the ascending aorta to the
PA, leading to increased pulmonary blood flow and heart
failure (type B3).4
PFAA can have a beneficial hemodynamic role in both
systemic–systemic and systemic–pulmonary configura-
tions. It serves as a conduit for systemic blood flow
when associated with aortic atresia, aortic arch interruption,
or aortic coarctation1 and pulmonary blood flow when
associated with pulmonary atresia.5 The varied clinical
presentation of this entity leads to misdiagnosis and under-From the Division of Cardiac and Vascular Surgerya and Transfusion Medicine and
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e118 The Journal of Thoracic and Cardiovascular Surestimation of the true incidence of PFAA. Gerlis and
colleagues1 report an incidence of 1 in 330 autopsy cases
in an analysis of 2000 pathologic specimens. Familiarity
with the different clinical presentations will aid in avoiding
misdiagnosis of this entity.References
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Inst J. 2006;33:361-4.Treatment of deep sternal wound infections after coronary artery
bypass grafting by means of injection of platelet gel: An
evolving technologyErez Kachel, MD,a Jeannie Callum, MD,b Fuad Moussa, MD,a Jenette Goldstein, MLT,b and
Stephen Fremes, MD,a Toronto, Ontario, CanadaDeep sternal wound infections (DSWIs) continue to be one
of the most devastating and potentially life-threatening com-
plications after cardiac surgery. Although most patients are
treated surgically, there is high rate of recurrent infection
or flap-related complications and mortality.1 Lately, nonsur-
gical methods, such as vacuum-assisted closure (VAC),
injection of activated macrophages, or both, have shown
promising results.2,3
Platelet gel (PG) contains concentrated levels of platelet-
secreted growth factors (platelet-derived growth factor and
vascular endothelial growth factor) and other substancesthat have the potential to accelerate wound healing, epitheli-
alization, and granulation tissue formation.4 Autologous PG
has been used in the treatment of various wound infections,
although not sternal wounds.2 We present a case using allo-
geneic PG to facilitate wound closure.CLINICAL SUMMARY
A 74-year-old diabetic, hypertensive, and morbidly obese
(body mass index, 42) woman was readmitted with sepsis
5 weeks after triple coronary artery bypass grafting with
a single pedicled thoracic artery. Before admission, the
patient was treated for 10 days with oral ciprofloxacin
because of sternal incision erythema. On admission, the ster-
num was now unstable with purulent discharge, and the
patient was critically ill, with respiratory failure requiring in-
tubation and mechanical ventilation; was hemodynamically
unstable, requiring vasopressor support; and had renal insuf-
ficiency. Cultures were taken, and intravenous vancomycin
was started. She was taken to the operating room on an emer-
gency basis for surgical debridement at which time the ster-
nal wires were removed, all grossly necrotic tissue wasgery c June 2010
FIGURE 1. Deep sternal wound infection before treatment. FIGURE 2. Two week after the first platelet gel injection.
FIGURE 3. Eight weeks after the first platelet gel injection.
Brief Clinical Reportsexcised, and the wound was left open. The diagnosis of
DSWI was established based on clinical judgment, intrao-
perative findings, and tissue, bone, and blood cultures,
results of which were positive for methicillin-resistant
Staphylococcus aureus sensitive to vancomycin (Figure 1).
The patient was treated with VAC for the next 4 weeks,
with minimal evidence of wound healing. Because she
was at high risk for sternal reconstruction failure because
of morbid obesity with a high volume of purulent discharge,
we treated her by injecting allogeneic PG into the sternal
wound, followed by another course of VAC.
In our institution bedside sternal debridement is per-
formed before PG injection. We inject the PG with
a 10-mL syringe, 0.1 mL/1 cm2 into the soft tissues and peri-
osteum, to a depth of 0.5 to 1 cm targeting viable tissue (ie,
not into fibrin or necrotic tissue). Thereafter, lactated
Ringer’s soaked sterile gauze pads are applied twice daily
for the next 2 days until the VAC system is reapplied.
The allogeneic PG is prepared as follows: a pool of group–
specific, buffy-coat–prepared, leukoreduced, bacterially de-
pleted platelets (4 donations) is centrifuged at 22C and
2400 rpm for 10 minutes. The plasma is extracted, leaving
approximately 50 mL of residual volume. The concentrated
platelets are resuspended gently in the remaining plasma by
means of gentle manipulation of the product. The product is
then left to rest for approximately 15 minutes and then placed
on the blood bank platelet agitator for another 30 minutes
before issue.
Two weeks after the first PG injection, the whole bone was
covered with strong, bright granulation tissue (Figure 2). Two
more doses were injected in 2-week intervals, and final closure
was achieved 8 weeks after the first injection (Figure 3).
DISCUSSION
The use of allogeneic PG for treatment of postoperative
DSWIs represents an innovative and conservative biologicThe Journal of Thoracic and Carapproach for this disastrous complication. The only 2 pub-
lished articles that used PG in cardiac surgeries applied
autologous PG on the wound surface area at the end of the
operation as prophylaxis against wound infection rather
than as therapy for established DSWI, as in our case.5
The combination of a very high-risk patient for a second
operation, the evidence that PG accelerates wound healing
in other disciplines, and the knowledge that PG contains
and secretes many growth factors involved in wound heal-
ing encouraged us to treat the patient with this novel ap-
proach. Although there is no scientific proof that PG was
responsible for the accelerated wound healing, wound heal-
ing had not progressed for at least 4 weeks after conven-
tional therapy, including operative debridement, local
wound care with a VAC dressing, and appropriate antibi-
otics. After injection of the PG and without introduction
of any other therapy, the wound was granulated in 2 weeks
without any further intervention.diovascular Surgery c Volume 139, Number 6 e119
Brief Clinical ReportsAllogeneic PG, as opposed to autologous PG, is preferred
because it can be obtained from young and healthy donors,
providing a high dose of functioning platelets with minimal
risk of bacterial contamination.
This is the first published report, to our knowledge, of
treating DSWI by means of injection of allogenic PG.
Considering the disappointing results seen with the sur-
gical treatment of DSWI, especially for high-risk pa-
tients, nonsurgical therapy consisting of a combination
of biologic (PG) and mechanical (VAC) methods might
be advantageous as a simple, inexpensive, and safer
therapy.From Medical College of Wisconsin, Milwaukee, Wis.
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2005;37:381-6.Right ventricular reverse remodeling is possible despite twenty-one
years of absent tricuspid valve and severe right ventricular failureRamohan Marla, MD, Judy Fox, RNP, Raymond Q. Migrino, MD, Lee Biblo, MD, and R. Eric Lilly, MD,
Milwaukee, WisRecovery of impaired right ventricular (RV) function after
tricuspid valve (TV) replacement for long-standing chronic
tricuspid regurgitation is not predictable. Poor preoperative
RV function and enlarged RV dimensions are not always
reversible after TV replacement. We report a case of com-
plete return to normal of RV dimensions and function after
TV replacement for severe tricuspid regurgitation of 21
years’ duration.TABLE 1. Right ventricular chamber dimensions preoperatively and
at 6 postoperative months of follow-up
Reference range Preoperative Follow-upCLINICAL SUMMARY
A 48-year-old woman with history of TV excision at
another institution 21 years previously for staphylococcal
endocarditis was admitted with class IV heart failure. Dur-
ing the ensuing 5 years, she had progressively worsening
functional status and finally was seen with overt right heart
failure in atrial flutter with ascites and pleural effusions. A
transthoracic echocardiogram revealed a small left ventri-
cle with leftward displacement of the interventricular
septum, severely dilated RV with diminished RV systolic
function, and absent TV (Figure 1, A–C). Right heart cath-
eterization revealed Fick-derived cardiac index of 1.57 L/(min/m2), pulmonary vascular resistance of 3.86 Wood
units, and pulmonary capillary wedge pressure of 19 mm
Hg. No coronary artery disease was noted on left heart
catheterization.
A 33-mm St Jude Biocor porcine valve (St Jude Medical,
Inc, St Paul, Minn) was sutured into the tricuspid position by
way of a resternotomy. Midrange inotropic support without
nitric oxide was required for successful weaning from car-
diopulmonary bypass. Cardiac index gradually improved,
and the patient was discharged home on postoperative day
14 in normal sinus rhythm. A transthoracic echocardiogram
obtained 6 months after surgery demonstrated RV reverse
remodeling with improved left ventricular geometry
(Figure 1, D–F) and normal RV dimensions, as defined by
the American Society of Echocardiography1 (Table 1). At
6 months, the patient had no signs of heart failure and nearly
normal exercise tolerance.Measurement (cm) (cm) (cm)
Right ventricular
basal diameter
2–2.8 5 2.8
Mid right
ventricular diameter
2.7–3.3 3.5 3.2
Base to apex length 7.1–7.9 7.5 7.2
Above aortic valve 2.5–2.9 5.6 4.4
Above pulmonic valve 1.7–2.3 2.7 2.1
Measurements and reference ranges were obtained according to standard American
Society of Echocardiography recommendation.1
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